Workineh Meseret, Mathewos Biniam, Moges Beyene, Gize Adissu, Getie Sisay, Stendahl Olle, Schon Thomas, Abate Ebba
Department of Immunology & Molecular Biology, School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
St. Paul's Millennium Medical College, Addis Ababa, Ethiopia.
Arch Public Health. 2017 Jun 19;75:25. doi: 10.1186/s13690-017-0195-7. eCollection 2017.
Recent studies suggest that the incidence and severity of tuberculosis is associated with low levels of vitamin D. Even though individuals living in Ethiopia have a high exposure to sunlight which is a source of vitamin D, tuberculosis is still one of the major causes of morbidity and mortality in the country. Therefore, this study aimed to determine the prevalence and associated factors of vitamin D deficiency in newly diagnosed tuberculosis patients, household contacts and community controls in Gondar, Ethiopia.
A comparative cross-sectional study design was conducted. Blood samples were collected from newly diagnosed smear positive pulmonary TB patients, their household contacts and community controls. Serum 25(OH)-vitamin D was determined by an Enzyme Linked Immunosorbent Assay. A serum level of 25(OH)-vitamin D below < 50 nmol/L was defined as vitamin D deficiency and <25 nmol/L as severe vitamin D deficiency.
A total of 126 newly diagnosed smear positive TB patients, 57 house hold contacts and 70 apparently community controls were included in the study. The mean ± SD age (years) of TB patients, house hold contacts and community controls was 29.8 ± 11.9, 24.3 ± 14.7 and 27.3 ± 7.6 respectively. Ninety out of 126 (71.4%) TB patients were underweight with a BMI of < 18.5 kg/m. The mean 25(OH)-vitamin D level of TB patients (30.1 ± 19.3 nmol/L) was significantly lower than community controls (38.5 ± 20.9 nmol/L, = 0.005 and household contacts (37.7 ± 12.8 nmol/L, =0.031).). The prevalence of vitamin D deficiency was higher in TB patients (83.3%) than in community controls (67.1%, = 0.009). The prevalence of vitamin D deficiency was also found higher in household contacts (80.7%). Severe vitamin D deficiency was observed in 53%(67/126), 30% (21/70), 19.3%(11/57) of TB patients, community controls and household contacts respectively. Low BMI (AOR = 2.13; 95%CI: 1.02, 3.28) and being positive for tuberculosis (AOR = 1.93; 95%CI: 1.06, 2.86) were significant predictors of severe vitamin D deficiency.
High prevalence of vitamin D deficiency was found among newly diagnosed TB patients and in their household contacts. The present study warrants further studies to determine the role of vitamin D supplementation in the prevention and treatment of tuberculosis in Ethiopia.
近期研究表明,结核病的发病率和严重程度与维生素D水平低下有关。尽管生活在埃塞俄比亚的人群暴露于作为维生素D来源的阳光下的机会很多,但结核病仍是该国发病和死亡的主要原因之一。因此,本研究旨在确定埃塞俄比亚贡德尔新诊断的结核病患者、家庭接触者和社区对照人群中维生素D缺乏的患病率及相关因素。
采用比较性横断面研究设计。采集新诊断的涂片阳性肺结核患者、其家庭接触者和社区对照人群的血样。采用酶联免疫吸附测定法测定血清25(OH)-维生素D水平。血清25(OH)-维生素D水平低于50 nmol/L被定义为维生素D缺乏,低于25 nmol/L为严重维生素D缺乏。
本研究共纳入126例新诊断的涂片阳性肺结核患者、57名家庭接触者和70名明显健康的社区对照人群。肺结核患者、家庭接触者和社区对照人群的平均年龄(岁)±标准差分别为29.8±11.9、24.3±14.7和27.3±7.6。126例(71.4%)肺结核患者体重过轻,体重指数(BMI)<18.5 kg/m。肺结核患者的平均25(OH)-维生素D水平(30.1±19.3 nmol/L)显著低于社区对照人群(38.5±20.9 nmol/L,P = 0.005)和家庭接触者(37.7±12.8 nmol/L,P = 0.031)。肺结核患者中维生素D缺乏的患病率(83.3%)高于社区对照人群(67.1%,P = 0.009)。家庭接触者中维生素D缺乏的患病率也较高(80.7%)。肺结核患者、社区对照人群和家庭接触者中严重维生素D缺乏的比例分别为53%(67/126)、30%(21/70)、19.3%(11/57)。低BMI(调整后比值比[AOR]=2.13;95%置信区间[CI]:1.02,3.28)和结核菌素试验阳性(AOR = 1.93;95%CI:1.06,2.86)是严重维生素D缺乏的显著预测因素。
新诊断的肺结核患者及其家庭接触者中维生素D缺乏的患病率较高。本研究有必要进一步开展研究,以确定补充维生素D在埃塞俄比亚结核病预防和治疗中的作用。